go-v.orgdoi

Exploring SLC16A1 as an Oncogenic Regulator and Therapeutic Target in Cholangiocarcinoma

Jianxin Huang, Fahui Liu, Donghua Liu, Shihang Tang, Dong‐Yan Shen · Journal of Cancer · 2024

  • DOI 10.7150/jca.95258
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2024

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2024

Abstract

experiments, we confirmed that SLC16A1, as an oncogene in CCA, promotes the growth of CCA cells and chemoresistance. Knocking down SLC16A1 inhibited the growth of CCA cells and enhanced their sensitivity to 5-Fluorouracil (5-FU). Overall, this study reveals the key role of SLC16A1 in the development of CCA and highlights its significance as a potential target for improving treatment efficacy and chemotherapy sensitivity.

Open the resolved locator · 10.7150/jca.95258

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:24 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v15p3794.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.